Aspen Holdings strikes NZ infant formula deal
South African pharma group Aspen Holdings has snapped up 50% of New Zealand infant formula producer New Zealand New Milk.
Pfizer
Nestle offloads baby food brands Alete, Milasan to BWK
Nestle has sold baby food brands Alete and Milasan to German investment firm BWK for an undisclosed sum.
S AFRICA/MEXICO: Aspen buys Nestle’s Mexico baby food assets
South African pharmaceutical group Aspen Pharmacare has acquired Nestle's infant milk factory in Mexico and licences for some of its brands in Latin America.
In the spotlight: The verdict from China’s infant formula probe
International infant formula manufacturers are adjusting their business practices in China having been found guilty of price fixing. Multinational companies, which were the focus of an anti-trust investigation, say they have emerged from the probe with a "clearer understanding" of the regulatory framework in the country. However, some pundits suggest the probe must be viewed in the context of a wider government push to boost the domestic industry. Katy Askew reports.
The just-food interview part two: Nestle “best placed” to meet Chinese challenge
Nestle is witnessing dynamic growth in China thanks to a combination of M&A and organic growth. As we discovered in part one of this two part interview, regional chief Roland Decorvet attributes much of this success to Nestle's use of local and global brands. But operating in China is not without its challenges. Katy Askew caught up with Decorvet to find out more about why he believes Nestle is best-placed of all the multinationals to succeed in China.
The just-food interview part one: Nestle China CEO sees dynamic growth
The potential offered by the Chinese market is nothing new. And nor is Nestle's presence in the country. The world's largest food group started trading in Hong Kong in 1874…
AFRICA/AUS: Aspen to buy Pfizer infant assets in Nestle deal
Aspen Pharmacare is to acquire the Pfizer infant nutrition businesses in Australia and southern Africa after a deal with Nestle worth US$215m. The agreement comes after regulators in Australia and…
MEXICO: Nestle to sell Pfizer assets to settle competition concerns
Nestle will sell Pfizer's Mexican business to settle competition issues in the market arising from its deal last year to buy the pharmaceutical giant's infant nutrition operations worldwide. The Mexican…
just-food confidence survey – China dominates emerging market interest
just-food's Confidence Survey asked for your views on the emerging markets and, in particular, which of the BRIC economies you expected to offer the greatest opportunity in 2013. While the…
just-food confidence survey: M&A appetite grows but will deals be done?
just-food's industry confidence survey for 2013 indicated an increased appetite for M&A this year after what some saw, globally, as a lacklustre year in the sector for deals. What lies…
EXCLUSIVE: CAGE: Mead Johnson upbeat on China despite Nestle expansion
Mead Johnson has dismissed any suggestions Nestle will prove to be formidable competition in China following the Swiss food group's acquisition of Pfizer's baby food business. Stephen Golsby, president and…
